Valuation: WEED, Inc.

Market Cap 4.26M 3.75M 3.54M 3.21M 6.04M 409M 6.07M 42.33M 16.35M 209M 15.99M 15.64M 671M P/E 2024
-7.8x
P/E 2025 -4.28x
Enterprise Value 4.74M 4.17M 3.95M 3.58M 6.72M 455M 6.76M 47.15M 18.21M 232M 17.81M 17.43M 747M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
40.53%
Yield 2024 *
-
Yield 2025 -
1 day-0.42%
1 week+4.38%
Current month-4.35%
1 month-4.35%
3 months-0.74%
6 months+30.00%
Current year-33.86%
1 week 0.02
Extreme 0.0248
0.03
1 month 0.02
Extreme 0.0232
0.03
Current year 0.02
Extreme 0.0159
0.05
1 year 0.02
Extreme 0.0159
0.08
3 years 0.02
Extreme 0.0159
0.11
5 years 0.02
Extreme 0.0159
0.49
10 years 0.02
Extreme 0.0159
15.2
Manager TitleAgeSince
Chief Executive Officer 73 2014-09-29
Corporate Secretary 49 2014-09-29
Director TitleAgeSince
Director/Board Member 49 2004-12-31
Director/Board Member 73 2004-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/18/26 Sell

Director

-50,000 0.0337%
5/29/26 Sell

Director

-5,008 0.0034%
2/24/26 Sell

Director

240,605 0.1770%
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%+4.38%-26.67%-71.40% 4.26M
+2.64%+7.07%+11.87%+38.40% 47.97B
+0.22%+1.71%+50.91%+34.00% 44.5B
-1.58%+5.65%+359.34%+598.06% 43.93B
+1.70%+4.61%+12.56%+90.97% 41.03B
+0.51%-0.61%+5.18%+46.87% 29.85B
-0.48%+0.59%+23.98%+148.36% 17.27B
+0.08%+9.30%+8.41% - 15.34B
+1.76%+2.98%+29.13%+45.78% 15.3B
+1.97%-2.82% - - 14.82B
Average +0.55%+2.70%+52.75%+116.38% 27B
Weighted average by Cap. +0.69%+2.97%+79.47%+158.52%

Financials

2024 2025
Net sales - -
Net income -511K -449K -425K -385K -724K -49.01M -728K -5.08M -1.96M -25.02M -1.92M -1.88M -80.4M -1.37M -1.21M -1.14M -1.04M -1.94M -132M -1.96M -13.64M -5.27M -67.22M -5.15M -5.04M -216M
Net Debt 292K 257K 243K 220K 414K 28.04M 416K 2.9M 1.12M 14.31M 1.1M 1.07M 46M 485K 426K 403K 366K 687K 46.54M 691K 4.82M 1.86M 23.75M 1.82M 1.78M 76.35M
Logo WEED, Inc.
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
Employees
2
Date Price Change Volume
26-09-28 US$0.0286 -0.42% 67,410
26-09-25 US$0.0287 -0.55% 157,543
26-09-24 US$0.0289 +10.48% 38,595
26-09-23 US$0.0261 -4.60% 3,418
26-09-22 US$0.0274 +9.60% 6,793
  1. Stock Market
  2. Stocks
  3. BUDZ Stock